6 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... suspension 400 mg PO BID ... mucosal #IDSA #Prevention ... #Treatment #management ... #opportunistic
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
Recommendations for Preventing ... Alternative Management ... agents may be used ... 500–1000 mg PO BID ... #opportunistic
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Prophylaxis: • If used ... for 3 days, then BID ... with ARV (see Table ... #Treatment #management ... #opportunistic
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Clarithromycin 500 mg PO BID ... please refer to Table ... recommendation when used ... #Treatment #management ... #opportunistic
Enema Selection / Comparison Table

A short guide for choosing which enema to order depending on the
Enema Selection / Comparison ... Table A short ... Contraindications: Colitis, IBD ... Notes: Typical used ... #Constipation #Management
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Please refer to the table ... ARV drugs when used ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management ... #opportunistic